These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24400912)

  • 1. Set-valued dynamic treatment regimes for competing outcomes.
    Laber EB; Lizotte DJ; Ferguson B
    Biometrics; 2014 Mar; 70(1):53-61. PubMed ID: 24400912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Q-learning residual analysis: application to the effectiveness of sequences of antipsychotic medications for patients with schizophrenia.
    Ertefaie A; Shortreed S; Chakraborty B
    Stat Med; 2016 Jun; 35(13):2221-34. PubMed ID: 26750518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.
    Butler EL; Laber EB; Davis SM; Kosorok MR
    Biometrics; 2018 Mar; 74(1):18-26. PubMed ID: 28742260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic treatment regimes: practical design considerations.
    Lavori PW; Dawson R
    Clin Trials; 2004 Feb; 1(1):9-20. PubMed ID: 16281458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of personalized Dynamic Treatment Regimes (DTRs) and Sequential Multiple Assignment Randomized Trials (SMARTs) in mental health studies.
    Liu Y; Zeng D; Wang Y
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):376-83. PubMed ID: 25642116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.
    Orellana L; Rotnitzky A; Robins JM
    Int J Biostat; 2010; 6(2):Article 8. PubMed ID: 21969994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.
    Zhao YQ; Zeng D; Laber EB; Kosorok MR
    J Am Stat Assoc; 2015; 110(510):583-598. PubMed ID: 26236062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using decision lists to construct interpretable and parsimonious treatment regimes.
    Zhang Y; Laber EB; Tsiatis A; Davidian M
    Biometrics; 2015 Dec; 71(4):895-904. PubMed ID: 26193819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doubly robust estimation of optimal dynamic treatment regimes with multicategory treatments and survival outcomes.
    Zhang Z; Yi D; Fan Y
    Stat Med; 2022 Oct; 41(24):4903-4923. PubMed ID: 35948279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inference for non-regular parameters in optimal dynamic treatment regimes.
    Chakraborty B; Murphy S; Strecher V
    Stat Methods Med Res; 2010 Jun; 19(3):317-43. PubMed ID: 19608604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesizing independent stagewise trials for optimal dynamic treatment regimes.
    Chen Y; Wang Y; Zeng D
    Stat Med; 2020 Dec; 39(28):4107-4119. PubMed ID: 32804414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.
    Liu Y; Wang Y; Kosorok MR; Zhao Y; Zeng D
    Stat Med; 2018 Nov; 37(26):3776-3788. PubMed ID: 29873099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive contrast weighted learning for multi-stage multi-treatment decision-making.
    Tao Y; Wang L
    Biometrics; 2017 Mar; 73(1):145-155. PubMed ID: 27213913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic treatment regimes: technical challenges and applications.
    Laber EB; Lizotte DJ; Qian M; Pelham WE; Murphy SA
    Electron J Stat; 2014; 8(1):1225-1272. PubMed ID: 25356091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making.
    Foussias G; Remington G
    Can J Psychiatry; 2010 Mar; 55(3):117-25. PubMed ID: 20370961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREE-BASED REINFORCEMENT LEARNING FOR ESTIMATING OPTIMAL DYNAMIC TREATMENT REGIMES.
    Tao Y; Wang L; Almirall D
    Ann Appl Stat; 2018 Sep; 12(3):1914-1938. PubMed ID: 30984321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reward ignorant modeling of dynamic treatment regimes.
    Wallace MP; Moodie EEM; Stephens DA
    Biom J; 2018 Sep; 60(5):991-1002. PubMed ID: 29845644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.